|
Compound design, synthesis and
evaluation
Our clients benefit from our 18 years of experience in small
molecule drug discovery and development. To date, two
discovery projects with which we were involved have reached
Phase II clinical trials. Our expertise includes:
·
target
identification
·
hit
finding
·
hit-to-lead chemistry
·
lead
optimization
·
preclinical development
·
clinical
development
Advising clients in development candidate selection is aided by
our drug development experience.
In the discovery arena, we can help you to:
·
interpret structure-activity relationships
·
design
new drug-like compounds and synthetic routes to them
·
identify
and prioritize assays for compound evaluation
·
prioritize compounds and chemical series for further
development
·
choose
and implement equipment for compound synthesis, purification
and characterization
·
select
contract laboratories to augment your internal capabilities
To learn
about our other service offerings, click here.
|
